デフォルト表紙
市場調査レポート
商品コード
1712546

デジタルホログラフィック顕微鏡の世界市場:2025年~2033年

Global Digital Holographic Microscopy Market - 2025-2033


出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
デジタルホログラフィック顕微鏡の世界市場:2025年~2033年
出版日: 2025年04月22日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のデジタルホログラフィック顕微鏡の市場規模は、2024年に4億7,660万米ドルとなりました。同市場は、2033年には30億5,689万米ドルに達し、予測期間の2025年~2033年に20.4%のCAGRで拡大すると予測されています。

デジタルホログラフィック顕微鏡(DHM)は、干渉計アーキテクチャを用いた定量位相イメージング(QPI)の一般的な技術です。単素子干渉計は、そのシンプルさ、安定性、低コストにより、特に有用です。単素子反射型デジタルホログラフィック顕微鏡(SER-DHM)と呼ばれるシンプルなコモンパス干渉計レイアウトは、照明とデジタルホログラムの生成に単一の1次元回折格子を使用します。この技術は、シングルショット動作原理を使用して、反射/不透明物体のQPIとトポグラフィー解析を可能にし、実験的に検証されています。

世界のデジタルホログラフィック顕微鏡市場は、イメージングとディスプレイ技術の進歩により成長しています。カメラ解像度、光源、センサ、リアルタイム画像処理の改良により、DHMシステムの性能、精度、使いやすさが向上しています。高速カメラと高感度検出器により、研究者はダイナミックな生物学的プロセスを極めて鮮明かつ時間分解能で捉えることができます。

3Dディスプレイ技術とソフトウェア駆動の可視化ツールにより、複雑なホログラフィック・データをリアルタイムで再構成・解釈することが可能になり、より直感的でインタラクティブな検体分析が容易になっています。このような進歩により、正確でラベルフリーかつ定量的なイメージングが重要な、細胞生物学、ナノテクノロジー、材料科学におけるDHMの用途が拡大した。イメージングとディスプレイの技術が進化するにつれ、技術的な複雑さや操作上の制約が軽減され、学術、臨床、産業の各領域でDHMがより身近で魅力的なものになると期待されています。

世界のデジタルホログラフィック顕微鏡市場は、導入コストが高いという課題に直面しています。高度なシステムには、高度な光学部品、高解像度カメラ、強力なデータ処理ソフトウェアが必要であり、初期投資がかさみます。既存のラボへの統合には、インフラの改造や専門的なトレーニングが必要な場合があり、運用コストがさらに増加します。こうしたコストは、予算が限られている中小規模の研究機関や研究開発にとって障壁となり、特に発展途上地域や資金力の乏しい組織では、普及が遅れる可能性があります。

当レポートでは、世界のデジタルホログラフィック顕微鏡市場について調査し、市場の概要とともに、顕微鏡タイプ別、用途別、エンドユーザー別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 経営者の洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーとパイオニア
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 顕微鏡タイプ別

  • トランスミッション型DHM
  • 反射型DHM
  • オフアクシス型DHM
  • インライン型DHM

第6章 用途別

  • ライフサイエンス
  • 材料科学
  • 半導体
  • マイクロエレクトロニクス
  • その他

第7章 エンドユーザー別

  • 学術研究機関
  • 製薬・バイオテクノロジー企業
  • 病院・診療所
  • 製造業

第8章 地域市場分析と成長機会

  • 北米
    • 地域特有の主要な動向
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 地域特有の主要な動向
      • ドイツ
      • 英国
      • フランス
      • スペイン
      • イタリア
      • その他
  • 南米
    • 地域特有の主要な動向
      • ブラジル
      • アルゼンチン
      • その他
  • アジア太平洋
    • 地域特有の主要な動向
      • 中国
      • インド
      • 日本
      • 韓国
      • その他
  • 中東・アフリカ
    • 地域特有の主要な動向

第9章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要市場参入企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併・買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第10章 企業プロファイル

  • Lyncee Tec
    • 会社概要
    • 製品ポートフォリオ
    • 財務概要
    • 主な発展
    • SWOT分析
  • Holoxica Limited
  • Phase Holographic Imaging AB
  • Ovizio Imaging Systems
  • Nanolive SA
  • Holmarc Opto-Mechatronics Ltd
  • DAEIL SYSTEMS CO., LTD

第11章 仮定と調査手法

第12章 付録

目次
Product Code: HCIT9511

The global digital holographic microscopy market reached US$ 476.60 million in 2024 and is expected to reach US$ 3056.89 million by 2033, growing at a CAGR of 20.4% during the forecast period 2025-2033.

Digital holographic microscopy (DHM) is a popular technique for quantitative phase imaging (QPI) using interferometric architectures. Single-element interferometers are particularly useful due to their simplicity, stability, and low cost. A simple common-path interferometric layout called single-element reflective digital holographic microscopy (SER-DHM) uses a single one-dimensional diffraction grating for illuminating and generating digital holograms. This technique enables QPI and topography analysis of reflective/opaque objects using a single-shot operation principle, which has been experimentally validated.

Market Dynamics: Drivers & Restraints

Advancements in Imaging and Display Technologies

The global digital holographic microscopy market is growing due to advancements in imaging and display technologies. Improvements in camera resolution, light sources, sensors, and real-time image processing have improved the performance, accuracy, and usability of DHM systems. High-speed cameras and high-sensitivity detectors enable researchers to capture dynamic biological processes with exceptional clarity and temporal resolution.

3D display technologies and software-driven visualization tools have made it possible to reconstruct and interpret complex holographic data in real-time, facilitating more intuitive and interactive analysis of specimens. These advancements have expanded DHM applications in cell biology, nanotechnology, and material science, where precise, label-free, and quantitative imaging is critical. As imaging and display technologies evolve, they are expected to reduce technical complexity and operational limitations, making DHM more accessible and appealing across academic, clinical, and industrial domains.

High Cost of Implementation

The global digital holographic microscopy market faces challenges due to high implementation costs. Advanced systems require sophisticated optical components, high-resolution cameras, and powerful data processing software, increasing initial investment. Integration into existing labs may require infrastructure modifications and specialized training, further increasing operational expenses. These costs can be a barrier for small- and medium-sized research institutions or labs with limited budgets, slowing widespread adoption, especially in developing regions or organizations with limited financial resources.

Segment Analysis

The global digital holographic microscopy market is segmented based on microscope type, application, end-user, and region.

Microscope Type:

The transmission DHM from the microscope type segment is expected to dominate the digital holographic microscopy market with the highest market share.

Transmission Digital Holographic Microscopy (DHM) is a sophisticated imaging technique that uses light transmission to capture holograms of microscopic structures. It records the phase shift of light waves, allowing for quantitative phase imaging and three-dimensional visualization without the need for dyes or labels.

The increasing demand for non-invasive imaging methods is driving the adoption of transmission digital holographic microscopy (DHM). This technique offers high-resolution, quantitative phase imaging of live cells, making it ideal for biomedical research, pharmaceutical development, pathology, cell biology, virology, and cancer diagnostics. It also supports long-term live-cell imaging without phototoxic effects, making it suitable for regenerative medicine and stem cell research. As academic institutions invest in high-end imaging systems, DHM adoption is expected to rise.

Geographical Analysis

North America is expected to hold a significant position in the digital holographic microscopy market, with the highest market share

North America is expected to dominate the global digital holographic microscopy market due to its advanced research facilities and healthcare infrastructure. The demand for non-invasive imaging techniques in biomedical research and clinical diagnostics has accelerated their adoption. Investments in nanotechnology, life sciences, and material science research, particularly in the US, are driving market growth. The presence of leading microscopy and imaging technology companies and government funding for R&D initiatives further enhances the market's expansion. The focus on precision medicine and real-time cellular imaging is expected to drive demand for digital holographic microscopy solutions.

For instance, in September 2024, Researchers have created a smartphone-based digital holographic microscope that offers precise 3D measurements, potentially expanding its applications to educational settings and point-of-care diagnostics in resource-limited settings.

Competitive Landscape

The major global players in the digital holographic microscopy market include Lyncee Tec, Holoxica Limited, Phase Holographic Imaging AB, Ovizio Imaging Systems, Nanolive SA, Holmarc Opto-Mechatronics Ltd, and DAEIL SYSTEMS CO., LTD, among others.

Key Developments

  • In March 2025, Honeywell introduced Digital Holographic Microscopy (DHM), a technology that uses artificial intelligence to efficiently count and classify microscopic particles or cells, offering significant potential in industries requiring rapid analysis and streamlined operations.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global digital holographic microscopy market report delivers a detailed analysis with 70 key tables, more than 74 visually impactful figures, and 165 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Microscope Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Advancements in Imaging and Display Technologies
      • 3.1.1.2. Increasing Need for 3D Visualization and Analysis
    • 3.1.2. Restraints
      • 3.1.2.1. High Cost of Implementation
      • 3.1.2.2. Technical Challenges and Limitations
    • 3.1.3. Opportunity
      • 3.1.3.1. Integration with Augmented Reality (AR) and Virtual Reality (VR)
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest largest-selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Force Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. By Microscope Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 5.1.2. Market Attractiveness Index, By Microscope Type
  • 5.2. Transmission DHM*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Reflection DHM
  • 5.4. Off-axis DHM
  • 5.5. Inline DHM

6. By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Life Sciences*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Material Sciences
  • 6.4. Semiconductors
  • 6.5. Microelectronics
  • 6.6. Others

7. By End User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 7.1.2. Market Attractiveness Index, By End User
  • 7.2. Academic & Research Institutes*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Pharmaceutical & Biotechnology Companies
  • 7.4. Hospitals & Clinics
  • 7.5. Manufacturing Industries

8. Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of Latin America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Microscope Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Lyncee Tec*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
      • 10.1.2.4. Product Sales Volume
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. Holoxica Limited
  • 10.3. Phase Holographic Imaging AB
  • 10.4. Ovizio Imaging Systems
  • 10.5. Nanolive SA
  • 10.6. Holmarc Opto-Mechatronics Ltd
  • 10.7. DAEIL SYSTEMS CO., LTD

LIST NOT EXHAUSTIVE

11. Assumptions and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us